4-(2-pyridyl)-o-cresol | 161037-66-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 4-(2-pyridyl)-o-cresol
• 英文别名: 2-Methyl-4-(pyridin-2-yl)phenol；2-methyl-4-pyridin-2-ylphenol
• CAS: 161037-66-7
• 化学式: C₁₂H₁₁NO
• 分子量: 185.225
• InChiKey: VUBUTQBNEHUTFM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  33.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(2-pyridyl)-o-cresol 在 吡啶 、 N-溴代丁二酰亚胺(NBS) 、 过氧化苯甲酰 作用下， 以 四氯化碳 为溶剂， 反应 9.0h， 生成 2-bromomethyl-4-(2-pyridyl)phenyl acetate
  参考文献：
  名称：

  Kasturi, T. R.; Mandal, A. B.; Sridevi, G., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1995, vol. 34, # 1, p. 1 - 5

  摘要：

  DOI：
• 作为产物：
  描述：

  4-溴-2-甲基苯酚 在 sodium hydroxide 、 氢溴酸 、 lithium 、 溶剂黄146 作用下， 反应 16.5h， 生成 4-(2-pyridyl)-o-cresol
  参考文献：
  名称：

  Kasturi, T. R.; Mandal, A. B.; Sridevi, G., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1995, vol. 34, # 1, p. 1 - 5

  摘要：

  DOI：

文献信息

• Palladium-Catalyzed Regioselective C–H Functionalization of Arenes Substituted by Two <i>N</i>-Heterocycles and Application in Late-Stage Functionalization
  作者：Da-Wei Yin、Gang Liu

  DOI：10.1021/acs.joc.8b00322

  日期：2018.4.6

  Pd-catalyzed regioselective C–H activation method that is used for C–H deuteration, carbonylation, halogenation, and oxidation of arene substrates substituted by two N-heterocycles. When conducted in acetic acid (AcOH), these reactions occur at the five-membered palladacycle sites, whereas they switch to the six-membered palladacycle sites in trifluoroacetic acid (TFA). This controllable regioselective C–H

  本文报道了一种钯催化的区域选择性C–H活化方法，用于C–H氘代，羰基化，卤化和氧化被两个N-杂环取代的芳烃底物。当在乙酸（AcOH）中进行时，这些反应发生在五元的Palladacycle位置，而它们切换到三氟乙酸（TFA）中的六元的Palladacycle位置。这种可控的区域选择性C–H激活被用于生物活性分子的后期功能化。一项机理研究表明，区域选择性是通过布朗斯台德酸-刘易斯碱相互作用和电子效应（在TFA中）以及palladacycle中间体的不同动力学稳定性（在AcOH中）实现的。
• TETRAZOLINONE COMPOUNDS AND APPLICATIONS THEREOF
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：US20160150787A1

  公开（公告）日：2016-06-02

  A tetrazolinone compound represented by formula (1): wherein Q represents a 6-membered aromatic heterocyclic group optionally having one or more atoms or groups selected from Group P 1 , provided that a heteroatom constituting the heterocyclic group is a nitrogen atom, and the number of nitrogen atom is 1, 2, or 3; R 1 , R 2 , R 3 , and R 11 each represents a C1-C6 alkyl group optionally having one or more atoms or groups selected from Group P 2 ; R 4 and R 5 each represents a hydrogen atom, etc.; R 6 represents a C1-C6 alkyl group optionally having one or more halogen atoms, etc.; R 7 , R 8 , and R 9 each represents a hydrogen atom, etc.; and X represents an oxygen atom or a sulfur atom, has excellent control activity against pests.

  一种由式（1）表示的四唑酮化合物：其中Q代表一个6元芳香杂环基，可选地具有来自P1组的一个或多个原子或基团，前提是构成杂环基的杂原子为氮原子，且氮原子的数量为1、2或3；R1、R2、R3和R11分别代表一个C1-C6烷基基团，可选地具有来自P2组的一个或多个原子或基团；R4和R5各代表一个氢原子，等等；R6代表一个C1-C6烷基基团，可选地具有一个或多个卤原子，等等；R7、R8和R9各代表一个氢原子，等等；X代表一个氧原子或硫原子，对害虫具有出色的控制活性。
• INFLAMMATORY CYTOKINE RELEASE INHIBITOR
  申请人：MUTO Susumu

  公开号：US20090192122A2

  公开（公告）日：2009-07-30

  A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient: wherein X represents a connecting group, A represents hydrogen atom or acetyl group, E represents an aryl group or a heteroaryl group, and ring X represents an arene or a heteroarene.

  一种具有抑制NF-κB激活活性的药物，其包括以下通式(I)所表示的化合物或其药理学上可接受的盐作为活性成分：其中X代表连接基，A代表氢原子或乙酰基，E代表芳基或杂芳基，环X代表芳烃或杂芳烃。
• MEDICAMENT FOR TREATMENT OF NEURODEGENERATIVE DISEASES
  申请人：MUTO Susumu

  公开号：US20080234233A1

  公开（公告）日：2008-09-25

  A medicament for preventive and/or therapeutic treatment of neurodegenerative diseases such as Alzheimer's disease or the like which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein A represents hydrogen atom or acetyl group, E represents a 2,5-di-substituted or a 3,5-di-substituted phenyl group, or a monocyclic or a fused polycyclic heteroaryl group which may be substituted, provided that the compound wherein said heteroaryl group is circle around (1)} a fused polycyclic heteroaryl group wherein the ring which binds directly to —CONH— group in the formula (I) is a benzene ring, circle around (2)} unsubstituted thiazol-2-yl group, or circle around (3)} unsubstituted benzothiazol-2-yl group is excluded, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group represented by formula —CONH-E wherein E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group represented by formula —CONH-E wherein E has the same meaning as that defined above.

  这是一种用于预防和/或治疗神经退行性疾病，如阿尔茨海默病等的药物，其包括以下通式（I）所表示的化合物中所选的一种作为活性成分，以及其药学上可接受的盐、水合物和溶剂化合物：其中，A代表氢原子或乙酰基，E代表2,5-二取代或3,5-二取代苯基，或单环或融合的多环杂环芳基，可以取代，但是当所述杂环芳基为圆圈1}在公式（I）中直接结合—CONH—基团的环为苯环，圆圈2}未取代的噻唑-2-基团，或圆圈3}未取代的苯并噻唑-2-基团时，排除在外，环Z代表一个芳烃，除了由公式—O-A所表示的基团和由公式—CONH-E所表示的基团外，还可以有一个或多个取代基，其中A具有上述定义的相同含义，E具有上述定义的相同含义，或者代表一个杂芳烃，除了由公式—O-A所表示的基团和由公式—CONH-E所表示的基团外，还可以有一个或多个取代基。
• ANTIALLERGIC AGENTS
  申请人：Muto Susumu

  公开号：US20080090779A1

  公开（公告）日：2008-04-17

  A medicament for the preventive and/or therapeutic treatment of allergic diseases and/or endometriosis and/or hysteromyoma which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in the main chain is 2 to 5 (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group represented by formula —X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group represented by formula —X-E wherein each of X and E has the same meaning as that defined above.

  一种预防和/或治疗过敏性疾病和/或子宫内膜异位症和/或子宫肌瘤的药物，其包括以下通式（I）所表示的化合物或其药学上可接受的盐、水合物和溶剂化物作为活性成分，其中X表示连接基，其主链中原子数为2至5（该连接基可以被取代），A表示氢原子或乙酰基，E表示芳基或取代的杂芳基，环Z表示苯环，除了由公式-O-A表示的基团，该苯环还可以具有一个或多个取代基团，其中A的含义与上述定义相同，而由公式-X-E表示的基团中，每个X和E的含义也与上述定义相同，或者是一个杂环，除了由公式-O-A表示的基团，该杂环还可以具有一个或多个取代基团，其中A的含义与上述定义相同，而由公式-X-E表示的基团中，每个X和E的含义也与上述定义相同。